In contrast to molecular chaperones that couple protein folding to ATP hydrolysis, protein disulfide-isomerase (PDI) catalyzes protein folding coupled to formation of disulfide bonds (oxidative folding). However, we do not know how PDI distinguishes folded, partly-folded and unfolded protein substrates. As a model intermediate in an oxidative folding pathway, we prepared a two-disulfide mutant of basic pancreatic trypsin inhibitor (BPTI) and showed by NMR that it is partly-folded and highly dynamic. NMR studies show that it binds to PDI at the same site that binds peptide ligands, with rapid binding and dissociation kinetics; surface plasmon resonance shows its interaction with PDI has a Kd of ca. 10？5 M. For comparison, we characterized the interactions of PDI with native BPTI and fully-unfolded BPTI. Interestingly, PDI does bind native BPTI, but binding is quantitatively weaker than with partly-folded and unfolded BPTI. Hence PDI recognizes and binds substrates via permanently or transiently unfolded regions. This is the first study of PDI's interaction with a partly-folded protein, and the first to analyze this folding catalyst's changing interactions with substrates along an oxidative folding pathway. We have identified key features that make PDI an effective catalyst of oxidative protein folding – differential affinity, rapid ligand exchange and conformational flexibility.
References
[1]
Riemer J, Bulleid N, Herrmann JM (2009) Disulfide formation in the ER and mitochondria: two solutions to a common process. Science 324: 1284–1287.
[2]
van Anken E, Braakman I (2005) Versatility of the endoplasmic reticulum protein folding factory. Crit Rev Biochem Mol Biol 40: 191–228.
[3]
Arolas JL, Aviles FX, Chang J-Y, Ventura S (2006) Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem Sci 31: 292–301.
[4]
Anfinsen CB, Haber E, Sela M, White FH Jr (1961) The kinetics of formation of native ribonuclease during oxidation of the reduced chain. Proc Natl Acad Sci U S A 47: 1309–1314.
[5]
van Mierlo CPM, Darby NJ, Keeler J, Neuhaus D, Creighton TE (1993) Partially folded conformation of the (30–51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor: 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements. J Mol Biol 229: 1125–1149.
[6]
van Mierlo CPM, Kemmink J, Neuhaus D, Darby NJ, Creighton TE (1994) 1H NMR analysis of the partly-folded non-native two-disulphide intermediates (30–51, 5–14) and (30–51, 5–38) in the folding pathway of bovine pancreatic trypsin inhibitor. J Mol Biol 235: 1044–1061.
[7]
Talluri S, Rothwarf DA, Scheraga HA (1994) Structural characterization of a three-disulfide intermediate of ribonuclease A involved in both the folding and unfolding pathways. Biochemistry 33: 10437–10449.
[8]
Laity JH, Lester CC, Shimotakahara S, Zimmerman DE, Montelione E, et al. (1997) Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A. Biochemistry 36: 12683–12699.
[9]
van den Berg B, Chung EW, Robinson CV, Dobson CM (1999) Characterisation of the dominant oxidative folding intermediate of hen lysozyme. J Mol Biol 290: 781–796.
[10]
Narayan M, Welker E, Wedemeyer WJ, Scheraga HA (2000) Oxidative folding of proteins. Acc Chem Res 33: 805–812.
[11]
Goldberger RF, Epstein CJ, Anfinsen CB (1963) Acceleration of reactivation of reduced bovine pancreatic ribonuclease by a microsomal system from rat liver. J Biol Chem 238: 628–635.
[12]
Venetianer P, Straub FB (1963) The enzymic reactivation of reduced ribonuclease. Biochim Biophys Acta 67: 166–168.
[13]
Hatahet F, Ruddock LW (2009) Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal 11: 2807–50.
[14]
Shin HC, Song MC, Scheraga HA (2002) Effect of protein disulfide isomerase on the rate-determining steps of the folding of bovine pancreatic ribonuclease A. FEBS Lett 521: 77–80.
[15]
Shin HC, Scheraga HA (2000) Catalysis of the oxidative folding of bovine pancreatic ribonuclease A by protein disulfide isomerase. J Mol Biol 300: 995–1003.
[16]
van den Berg B, Chung EW, Robinson CV, Mateo PL, Dobson CM (1999) The oxidative refolding of hen lysozyme and its catalysis by protein disulfide isomerase. EMBO J 18: 4794–4803.
[17]
Creighton TE, Hillson DA, Freedman RB (1980) Catalysis by protein-disulphide isomerase of the unfolding and refolding of proteins with disulphide bonds. J Mol Biol 142: 43–62.
[18]
Creighton TE, Bagley CJ, Cooper L, Darby NJ, Freedman RB, et al. (1993) On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI): structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes. J Mol Biol 232: 1176–1196.
[19]
Weissman JS, Kim PS (1993) Efficient catalysis of disulphide bond rearrangements by protein disulphide isomerase. Nature 365: 185–188.
[20]
Creighton TE (1974) The single-disulphide intermediates in the refolding of reduced pancreatic trypsin inhibitor. J Mol Biol 87: 603–624.
[21]
Creighton TE (1975) The two-disulphide intermediates and the folding pathway of reduced pancreatic trypsin inhibitor. J Mol Biol 95: 167–199.
[22]
Weissman JS, Kim PS (1991) Reexamination of the folding of BPTI: predominance of native intermediates. Science 253: 1386–1393.
[23]
Goldenberg DP (1992) Native and non-native intermediates in the BPTI folding pathway. Trends Biochem Sci 17: 257–261.
[24]
Darby NJ, Morin PE, Talbo G, Creighton TE (1995) Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates. J Mol Biol 249: 463–477.
[25]
Karala AR, Ruddock LW (2007) Does S-methyl methanethiosulfonate trap the thiol-disulfide state of proteins? Antioxid Redox Signal 9: 527–531.
[26]
Byrne LJ, Sidhu A, Wallis AK, Ruddock LW, Freedman RB, et al. (2009) Mapping of the ligand binding site on the b' domain of human PDI; interaction with peptide ligands and the x-linker region. Biochem J 423: 209–217.
[27]
Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, et al. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins-Structure Function and Bioinformatics 59: 687–696.
[28]
Biamonti C (1996) Structural and dynamic investigations of macromolecular recognition processes by nuclear magnetic resonance spectroscopy. Thesis, Rutgers University.
[29]
Wagner G, Stassinopoulou CI, Wüthrich K (1984) Amide-proton exchange studies by two-dimensional correlated 1H NMR in two chemically modified analogs of the basic pancreatic trypsin inhibitor. Eur J Biochem 145: 431–436.
[30]
Klappa P, Ruddock LW, Darby NJ, Freedman RB (1998) The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J 17: 927–35.
[31]
Freedman RB, Klappa P, Ruddock LW (2002) Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep 3: 136–40.
[32]
Pirneskoski A, Klappa P, Lobell M, Williamson RA, Byrne L, et al. (2004) Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J Biol Chem 279: 10374–81.
[33]
Nguyen VD, Wallis AK, Howard MJ, Haapalainen AM, Salo KEH, et al. (2008) Alternative conformations of the x region of human protein disulphide-isomerase modulate exposure of the substrate binding b' domain. J Mol Biol 383: 1144–55.
[34]
Denisov AY, Maattanen P, Dabrowski C, Kozlov G, Thomas DY, et al. (2009) Solution structure of the bb' domains of human protein disulfide isomerase. FEBS J 276: 1440–9.
[35]
Kozlov G, Maattanen P, Thomas DY, Gehring K (2010) A structural overview of the PDI family of proteins. FEBS J 277: 3924–3936.
[36]
Williamson RA, Carr MD, Frenkiel TA, Feeney J, Freedman RB (1997) Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry 36: 13882–13889.
[37]
Jansens A, van Duijn E, Braakman I (2002) Coordinated nonvectorial folding in a newly synthesized multidomain protein. Science 298: 2401–3.
[38]
Land A, Zonneveld D, Braakman I (2003) Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J 17: 1058–67.
[39]
Ellis RJ (2001) Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr Opin Struc Biol 11: 114–119.
[40]
van den Berg B, Ellis RJ, Dobson CM (2001) Effects of macromolecular crowding on protein folding and aggregation. EMBO J 18: 6927–6933.
[41]
Karala AR, Lappi AK, Saaranen MJ, Ruddock LW (2009) Efficient peroxide- mediated oxidative folding of a protein at physiological pH and implications for oxidative folding in the endoplasmic reticulum. Antioxid Redox Signal 11: 963–970.
[42]
Bulleid NJ, Ellgaard L (2011) Multiple ways to make disulfides. Trends Biochem Sci 36: 485–492.
[43]
Wang L, Li SJ, Sidhu A, Zhu L, Liang Y, et al. (2009) Reconstitution of human Ero1-Lalpha/protein-disulfide isomerase oxidative folding pathway in vitro. Position-dependent differences in role between the a and a' domains of protein-disulfide isomerase. J Biol Chem 284: 199–206.
[44]
Nguyen VD, Saaranen MJ, Karala A-R, Lappi A-K, Wang L, et al. (2011) Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulphide bond formation. J Mol Biol 406: 503–515.
[45]
Masui S, Vavassori S, Fagioli C, Sitia R, Inaba K (2011) Molecular bases of cyclic and specific disulfide exchange between Ero1α and PDI. J Biol Chem 286: 16261–16271.
[46]
Jimenez-Roldan JE, Bhattacharya M, Wells SA, R？mer RA, Vishveshwara S, et al.. (2013) The dynamics and flexibility of protein disulphide-isomerase (PDI): simulations predict experimentally-observed domain motions. in preparation
[47]
Gruber CW, Cemazar M, Heras B, Martin JL, Craik DJ (2006) Protein disulphide isomerase: the structure of oxidative folding. Trends Biochem Sci 31: 455–464.
